Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Uncomplicated Plasmodium Falciparum Malaria”

40 trials

Showing 20 of 40 results

Not applicableStudy completedNCT00157885
What this trial is testing

A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.

Who this might be right for
Malaria, FalciparumMalaria, Vivax
Menzies School of Health Research 400
Testing effectiveness (Phase 2)Study completedNCT04546633
What this trial is testing

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Study completedNCT00386763
What this trial is testing

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Who this might be right for
MalariaFalciparum
Novartis 890
Not applicableStudy completedNCT00157833
What this trial is testing

Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Who this might be right for
Falciparum MalariaVivax Malaria
Menzies School of Health Research 750
Large-scale testing (Phase 3)Study completedNCT00344006
What this trial is testing

Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 1,395
Testing effectiveness (Phase 2)UnknownNCT01464125
What this trial is testing

Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults

Who this might be right for
Malaria
Jomaa Pharma GmbH 43
Testing effectiveness (Phase 2)UnknownNCT01361269
What this trial is testing

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Malaria
Zentopharm GmbH 100
Not applicableStudy completedNCT00157859
What this trial is testing

To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia

Who this might be right for
Falciparum MalariaVivax Malaria
Menzies School of Health Research 150
Testing effectiveness (Phase 2)Study completedNCT01860989
What this trial is testing

Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

Who this might be right for
Cure Rate
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Study completedNCT01213966
What this trial is testing

Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria, FalciparumMalaria, Vivax
Medicines for Malaria Venture 82
Testing effectiveness (Phase 2)Study completedNCT00243737
What this trial is testing

Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria

Who this might be right for
Malaria
Albert Schweitzer Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00331136
What this trial is testing

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 60
Early research (Phase 1)Study completedNCT02612545
What this trial is testing

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

Who this might be right for
Acute Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 216
Testing effectiveness (Phase 2)Study completedNCT05689047
What this trial is testing

Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)

Who this might be right for
Acute Malaria
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 38
Testing effectiveness (Phase 2)Study completedNCT01753323
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria
Novartis Pharmaceuticals 43
Large-scale testing (Phase 3)Study completedNCT00541385
What this trial is testing

Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients

Who this might be right for
Malaria
Medicines for Malaria Venture 535
Post-approval studies (Phase 4)Study completedNCT00444106
What this trial is testing

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

Who this might be right for
MalariaFalciparum
Novartis 265
Testing effectiveness (Phase 2)Study completedNCT00217451
What this trial is testing

Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin

Who this might be right for
Malaria
Albert Schweitzer Hospital 51
Large-scale testing (Phase 3)Ended earlyNCT04300309
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 28
Post-approval studies (Phase 4)Ended earlyNCT00386750
What this trial is testing

Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function

Who this might be right for
MalariaFalciparum
Novartis Pharmaceuticals 265
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation